|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04.06.25 - 17:03
|
Biocom California Appoints New Members to Its Board of Directors and Board of Governors (Business Wire)
|
|
|
SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today announced the appointment of Thierry Diagana, Ph.D., head of Global Health and California sites head for Novartis Biomedical Research; Stephen Hatke, vice president of operations and site head at Takeda's Thousand Oaks facility; and Kelly Hayes, assurance partner at Ernst & Young, to its board of directors. Additionally, Adam Lenain, member at Mintz Levin; Aaron K. Cohen, vice president, government affairs and public policy at Neurocrine Biosciences; and Diane Simeone, M.D., director of the Moores Cancer Center at University of California San Diego, were appointed to the board of governors.
“The addition of these accomplished leaders, scientists and policy changers brings strategic depth to our board of directors and board of governors,” said Tim Scott, president and CEO of Biocom California. “Their expertise in capital raising, public p...
|
|
|
|
|
02.06.25 - 23:00
|
Analyst Expectations For Neurocrine Biosciencess Future (Benzinga)
|
|
|
Latest Ratings for NBIX
DateFirmActionFromTo Mar 2022Piper SandlerDowngradesOverweightNeutral Feb 2022Goldman SachsUpgradesNeutralBuy Feb 2022Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for NBIX
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
